PuraPharm (HKSE:01498) Inventories, Finished Goods

: HK$0.0 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

PuraPharm's quarterly finished goods increased from Dec. 2022 (HK$77.3 Mil) to Jun. 2023 (HK$97.3 Mil) but then declined from Jun. 2023 (HK$97.3 Mil) to Dec. 2023 (HK$0.0 Mil).

PuraPharm's annual finished goods increased from Dec. 2021 (HK$61.5 Mil) to Dec. 2022 (HK$77.3 Mil) but then declined from Dec. 2022 (HK$77.3 Mil) to Dec. 2023 (HK$0.0 Mil).

PuraPharm Inventories, Finished Goods Historical Data

The historical data trend for PuraPharm's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PuraPharm Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

101.88

98.96

61.51

77.34

PuraPharm Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Inventories, Finished Goods																61.51	72.26	77.34	97.29	-

PuraPharm Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

PuraPharm (HKSE:01498) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PuraPharm Corporation Ltd (HKSE:01498) » Definitions » Inventories, Finished Goods

Traded in Other Exchanges

N/A

Address

Wireless Centre, Phase One, Unit 201-207, 2nd Floor, Hong Kong Science Park, Tai Po, New Territories, Hong Kong, HKG

Website

https://www.purapharm.com

PuraPharm Corporation Ltd is a Hong Kong-based Chinese medicine Company. It is engaged in the research and development, production, marketing and sale of concentrated Chinese medicine granules (CCMG) products marketed under the brand Nong's. In addition, the organization is engaged in rendering Chinese medical diagnostic services. The operating segments of the group are China CCMG, Hong Kong CCMG, Chinese healthcare products, Plantation and Clinics. It generates maximum revenue from the China CCMG segment mainly engages in the production and sale of CCMG products in China. The group derives revenue from the customers located in Hong Kong, Mainland China and Other countries.

PuraPharm (HKSE:01498) Headlines

No Headlines